Disruption of prepulse inhibition of the startle reflex by the preferential D3 agonist ropinirole in healthy males

Psychopharmacology

Volumn 194, Issue 3, 2007, Pages 289-295

  Giakoumaki, Stella G ^a   Roussos, Panos ^a   Frangou, Sophia ^b   Bitsios, Panos ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

D3 receptors; Healthy males; Prepulse inhibition; Ropinirole

Indexed keywords

DOPAMINE 3 RECEPTOR STIMULATING AGENT; PLACEBO; ROPINIROLE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; EYELID REFLEX; HABITUATION; HUMAN; HUMAN EXPERIMENT; MALE; PREPULSE INHIBITION; PRIORITY JOURNAL; SCORING SYSTEM; STARTLE REFLEX;

ADULT; CROSS-OVER STUDIES; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROMYOGRAPHY; HABITUATION, PSYCHOPHYSIOLOGIC; HUMANS; INDOLES; MALE; NEURAL INHIBITION; RECEPTORS, DOPAMINE D3; STARTLE REACTION; STUDENTS, MEDICAL;

EID: 34548552556     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0843-7     Document Type: Article

References (64)

1. Bitsios P, Giakoumaki SG, Frangou S (2005) The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values. Psychopharmacology (Berl) 182:114-152
2. Bitsios P, Giakoumaki SG, Theou K, Frangou S (2006) Increased prepulse inhibition of the acoustic startle response is associated with better strategy formation and execution times in healthy males. Neuropsychologia 44:2494-2499
3. Blumenthal TD (1996) Inhibition of the human startle response is affected by both prepulse intensity and eliciting stimulus intensity. Biol Psychol 44:85-104
4. Blumenthal TD (1997) Prepulse inhibition decreases as startle reactivity habituates. Psychophysiology 34:446-450
5. Boeckler F, Russig H, Zhang W, Lober S, Schetz J, Hubner H, Ferger B, Gmeiner P, Feldon J (2004) FAUC 213, a highly selective dopamine D4 receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia. Psychopharmacology (Berl) 175:7-17
6. Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia: human and animal studies. Arch Gen Psychiatry 47:181-188
7. Braff DL, Grillon C, Geyer MA (1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206-215
8. Braff DL, Swerdlow NR, Geyer MA (1999) Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am J Psychiatry 156:596-602
9. Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead JS, Swerdlow NR (2001) Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res 49:171-178
10. Braff DL, Light GA, Ellwanger J, Sprock J, Swerdlow NR (2005) Female schizophrenia patients have prepulse inhibition deficits. Biol Psychiatry 57:817-820
11. 3 receptor agonist (+)-PD 128907, in the rat. Neuropharmacology 35:285-294
12. Bristow LJ, Collinson N, Cook GP, Curtis N, Freedman SB, Kulagowski JJ, Leeson PD, Patel S, Ragan CI, Ridgill M, Saywell KL, Tricklebank MD (1997) L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests. J Pharmacol Exp Ther 283:1256-1263
13. British Medical Association and Royal Pharmaceutical Society of Great Britain (2006) British National Formulary, 52nd edn. British Medical Association and Royal Pharmaceutical Society of Great Britain, London
14. 2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat. Neuropsychopharmacology 12:139-145
15. Diaz J, Pilon C, Le Foll B, Gros C, Triller A, Schwartz JC, Sokoloff P (2000) Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci 20:8677-8684
16. Ellenbroek BA, Lubbers LJ, Cools AR (2002) The role of hippocampal dopamine receptors in prepulse inhibition. Eur J Neurosci 15:1237-1243
17. Factor SA (1999) Dopamine agonists. Med Clin North Am 83:415-443
18. Gerlach M, Double K, Arzberger T, Leblhuber F, Tatschner T, Riederer P (2003) Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum. J Neural Transm 11010:1119-1127
19. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156:117-154
20. Giakoumaki SG, Bitsios P, Frangou S (2006) The level of prepulse inhibition in healthy individuals may index cortical modulation of early information processing. Brain Res 1078:168-170
21. Gobert A, Lejeune F, Rivet JM, Cistarelli L, Millan MJ (1996) Dopamine D3 (auto) receptors inhibit dopamine release in the frontal cortex of freely moving rats in vivo. J Neurochem 66:2209-2212
22. Graham FK (1975) The more or less startling effects of weak prestimulation. Psychophysiology 12:238-248
23. Gurevich EV, Joyce JN (1999) Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology 20:60-80
24. Hazlett EA, Buchsbaum MS, Tang CY, Fleischman MB, Wei TC, Byne W, Haznedar MM (2001) Thalamic activation during an attention-to-prepulse startle modification paradigm: a functional MRI study. Biol Psychiatry 50:281-291
25. Jackson DM, Westlind-Danielsson A (1994) Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 64:291-370
26. Jeanneteau F, Funalot B, Jankovic J, Deng H, Lagarde JP, Lucotte G, Sokoloff P (2006) A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proc Natl Acad Sci USA 103:10753-10758
27. Jovanovic T, Szilagyi S, Chakravorty S, Fiallos AM, Lewison BJ, Parwani A, Schwartz MP, Gonzenbach S, Rotrosen JP, Duncan EJ (2004) Menstrual cycle phase effects on prepulse inhibition of acoustic startle. Psychophysiology 41:401-406
28. Joyce JN, Gurevich EV (1999) D3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics. Ann NY Acad Sci 877:595-613
29. Kumari V, Gray JA (1999) Smoking withdrawal, nicotine dependence and prepulse inhibition of the acoustic startle reflex. Psychopharmacology (Berl) 141:11-15
30. Kumari V, Sharma T (2002) Effects of typical and atypical antipsychotics on the detection of sensorimotor gating deficits: a critical evaluation of current evidence and directions for future research. Psychopharmacology (Berl) 162:97-101
31. Kumari V, Gray JA, Geyer MA, Ffytche D, Soni W, Mitterschiffthaler MT, Vythelingum GN, Simmons A, Williams SC, Sharma T (2003) Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects. Psychiatry Res 122:99-113
32. Kumari V et al (2006) A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics. Int J Neuropsychopharmacol (in press)
33. Lejeune F, Millan MJ (1995) Activation of dopamine D3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo. Eur J Pharmacol 275:R7-R9
34. Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berl) 94:507-514
35. Mansbach RS, Brooks EW, Sanner MA, Zorn SH (1998) Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition. Psychopharmacology (Berl) 135:194-200
36. Meador-Woodruff JH, Damask SP, Wang J, Haroutunian V, Davis KL, Watson SJ (1996) Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology 15:17-29
37. Morissette M, Goulet M, Grondin R, Blanchet P, Bedard PJ, Di Paolo T, Levesque D (1998) Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies. Eur J Neurosci 10:2565-2573
38. Murray AM, Ryoo HL, Gurevich E, Joyce JN (1994) Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. PNAS 91:11271-11275
39. Newman-Tancredi A, Cussac D, Audinot V, Nicolas JP, De Ceuninck F, Boutin JA, Millan MJ (2002) Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor. J Pharmacol Exp Ther 303:805-814
40. Okuyama S, Kawashima N, Chaki S, Yoshikawa R, Funakoshi T, Ogawa SI, Suzuki Y, Ikeda Y, Kumagai T, Nakazato A, Nagamine M, Tomisawa K (1999) A selective dopamine D4 receptor antagonist, NRA0160: a preclinical neuropharmacological profile. Life Sci 65:2109-2125
41. Park WK, Jeong D, Cho H, Lee SJ, Cha MY, Pae AN, Choi KI, Koh YH, Kong JY (2005) KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia. Pharmacol Biochem Behav 82:361-372
42. 2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia. Neuropsychopharmacology 3:211-218
43. 4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J Neurosci 19:4627-4633
44. Reavill C, Taylor SG, Wood MD, Ashmeade T, Austin NE, Avenell KY, Boyfield I, Branch CL, Cilia J, Coldwell MC, Hadley MS, Hunter AJ, Feffrey P, Jewitt F, Johnson CN, Jones DN, Medhurst AD, Middlemiss DN, Nash DJ, Riley GJ, Routledge C, Stemp G, Thewlis KM, Trail B, Vong AK, Hagan JJ (2000) Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A. J Pharmacol Exp Ther 294:1154-1165
45. Roussos PR, Theou K, Koutmeridou K, Karli K, Giakoumaki SG, Bitsios P (2006) The relationship of prepulse inhibition to COMT polymorphism Val158Met in healthy males. J Psychopharmacol Suppl 20:A19
46. Schwartz JC, Diaz J, Pilon C, Sokoloff P (2000) Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions. Brain Res Brain Res Rev 31:277-287
47. Sesack SR, Carr DB (2002) Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia. Physiol Behav 77:513-517
48. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22-33
49. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347:146-151
50. 3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. CNS Neurol Disord Drug Targets 5:25-43
51. Swerdlow NR, Auerbach P, Monroe SM, Harston H, Geyer MA, Braff DL (1993) Men are more inhibited than women by weak prepulses. Biol Psychiatry 34:253-260
52. Swerdlow NR, Filion D, Geyer MA, Braff DL (1995) "Normal" personality correlates of sensorimotor, cognitive and visuospatial gating. Biol Psychiatry 37:286-299
53. Swerdlow NR, Hartman PL, Auerbach PP (1997) Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biol Psychiatry 4:452-460
54. Swerdlow NR, Taaid N, Oostwegel JL, Randolph E, Geyer MA (1998) Towards a cross-species pharmacology of sensorimotor gating: effects of amantadine, bromocriptine, pergolide and ropiniroleon prepulse inhibition of acoustic startle in rats. Behav Pharmacol 9:389-396
55. Swerdlow NR, Eastvold A, Gerbranda T, Uyan KM, Hartman P, Doan Q, Auerbach P (2000) Effects of caffeine on sensorimotor gating of the startle reflex in normal control subjects: impact of caffeine intake and withdrawal. Psychopharmacology (Berl) 151:368-378
56. Swerdlow NR, Platten A, Shoemaker J, Pitcher L, Auerbach P (2001) Effects of pergolide on sensorimotor gating of the startle reflex in rats. Psychopharmacology (Berl) 158:230-240
57. Swerdlow NR, Stephany N, Shoemaker JM, Ross L, Wasserman LC, Talledo J, Auerbach PP (2002) Effects of amantadine and bromocriptine on startle and sensorimotor gating: parametric studies and cross-species comparisons. Psychopharmacology (Berl) 164:82-92
58. Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Shoemaker J, Auerbach PP (2003) Amphetamine effects on prepulse inhibition across-species: replication and parametric extension. Neuropsychopharmacology 28:640-650
59. 1 blockade, frontal lesions and dopamine denervation. Neurosci Lett 402:40-45
60. Thorne GL, Dawson ME, Schell AM (2005) Attention and prepulse inhibition: the effects of task-relevant, irrelevant, and no-task conditions. Int J Psychophysiol 56(2):121-128
61. 3 receptors. Behav Pharmacol 9:445-455
62. Vollenweider FX, Remensberger S, Hell D, Geyer MA (1999) Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans. Psychopharmacology (Berl) 143:365-372
63. Weike AI, Bauer U, Hamm AO (2000) Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol Psychiatry 47:61-70
64. Zhang M, Ballard ME, Kohlhaas KL, Browman KE, Jongen-Relo AL, Unger LV, Fox GB, Gross G, Decker MW, Drescher KU, Rueter LE (2006) Effect of dopamine D3 antagonists on PPI in DBA/2J mice or PPI deficit induced by neonatal ventral hippocampal lesions in rats. Neuropsychopharmacology 31:1382-1392